跳至主要内容
临床试验/NCT00634062
NCT00634062已完成4 期

Study of Lamotrigine Treatment of Affective Instability in Borderline Personality Disorder

Mclean Hospital1 个研究点 分布在 1 个国家目标入组 28 人开始时间: 2004年12月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
已完成
入组人数
28
试验地点
1
主要终点
Changes in score of Affective Lability Scale

研究概览

简要总结

This study investigates the hypothesis that instability in mood in patients with borderline personality disorder will respond the mood stabilizing medication lamotrigine.

详细描述

Affective instability is one of the most prominent symptoms in borderline personality disorder. Currently there are no prospective studies of treatment of this symptom with mood stabilizing medications. This study examines the effectiveness of lamotrigine compared to placebo in reducing emotional instability of several types in borderline patients. The types of emotional instability studied involve anger, anxiety, depression, and elation. Subjects entering this 12 week study will be blind to whether they are receiving active medication or placebo. They will be asked to report levels of instability in their mood on a weekly basis. They will also be asked weekly to rate the intensity of other symptoms of borderline personality disorder symptoms, such as unstable relationships, self-harm, and impulsive behaviors.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Triple (Participant, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 64 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • Clinical Diagnosis of Borderline Personality Disorder with high levels of emotional instability

排除标准

  • Clinical diagnosis of Bipolar Disorder
  • Clinical diagnosis of psychiatric disorder related to general medical condition
  • Clinical diagnosis of substance abuse disorder within the last 60 days
  • Clinical diagnosis of psychotic disorder
  • Previous treatment with lamotrigine
  • Pregnancy or nursing
  • Currently hospitalized
  • Active suicidal or homicidal ideation

研究组 & 干预措施

1

Active Comparator

干预措施: Lamotrigine (Drug)

2

Placebo Comparator

干预措施: Placebo (Drug)

结局指标

主要结局

Changes in score of Affective Lability Scale

时间窗: Baseline and then weekly for 12 weeks

Changes in the score of the Affective Lability Item of the Zanarini Rating Scale for Borderline Personality Disorder

时间窗: Baseline and then weekly for 12 weeks

次要结局

  • Scores of individual items on the Zanarini Rating Scale for Borderline Personality Disorder(Baseline and then weekly for 12 weeks)

研究者

申办方类型
Other

研究点 (1)

Loading locations...

相似试验